SWOG clinical trial number
S0408

A Phase II Trial of Neoadjuvant Capecitabine, Oxaliplatin and Bevacizumab for Resectable Colorectal Metastases in the Liver

0% Accrual
Accrual
0%
Closed
Phase
0% Accrual
Accrual
0%
Abbreviated Title
COLORECTAL
Activated
11/15/2006
Closed
04/01/2007
Participants
Limited: SWOG and ECOG Institutions Listed on the Title Page

Research committees

Gastrointestinal Cancer

Treatment

Oxaliplatin Bevacizumab Capecitabine